Skip to Content
Merck

M2004

N-Methyl-D-glucamine

99.0-100.5% (titration)

Synonym(s):

1-Deoxy-1-(methylamino)-D-glucitol, Meglumine

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Empirical Formula (Hill Notation):
C7H17NO5
CAS Number:
Molecular Weight:
195.21
UNSPSC Code:
12352104
NACRES:
NA.22
PubChem Substance ID:
EC Number:
228-506-9
Beilstein/REAXYS Number:
385906
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI

1S/C7H17NO5/c1-8-2-4(10)6(12)7(13)5(11)3-9/h4-13H,2-3H2,1H3/t4-,5+,6+,7+/m0/s1

SMILES string

CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO

InChI key

MBBZMMPHUWSWHV-BDVNFPICSA-N

assay

99.0-100.5% (titration)

form

powder

autoignition temp.

~662 °F

mp

129-131.5 °C (lit.)

Quality Level

Looking for similar products? Visit Product Comparison Guide

General description

N-Methyl-D-glucamine, also known as methylglucamine, is an organic compound that belongs to the class of amino sugars. It is commonly used in pharmaceutical and biochemical applications as a resolving and buffering agent. Salts of N-methyl-D-glucamine have also been used for X-ray contrast media and nuclear imaging agents.

Application

N-Methyl-D-glucamine (NMG) can be used as a reactant to prepare water-soluble polymer for the selective removal of arsenic from aqueous water. It is also used in the development of various resins and gels containing NMG to remove different oxyanions.

Storage Class

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Ingrid Millet et al.
Radiology, 270(1), 57-66 (2013-09-14)
To retrospectively compare the kinetic magnetic resonance (MR) imaging characteristics of invasive breast carcinomas with both prognostic tumoral and patient-related parameters. This HIPAA-compliant retrospective study was approved by the institutional review board, and informed consent was waived. From January 2008
Philipp Kickingereder et al.
Neuro-oncology, 17(8), 1139-1147 (2015-03-11)
To analyze the relevance of dynamic susceptibility-weighted contrast-enhanced MRI (DSC-MRI) derived relative cerebral blood volume (rCBV) analysis for predicting response to bevacizumab (BEV) in patients with recurrent glioblastoma (rGB). A total of 127 patients diagnosed with rGB receiving either bevacizumab
Charlotte Manisty et al.
Radiology, 276(3), 732-740 (2015-04-30)
To investigate the pharmacology and potential clinical utility of splenic switch-off to identify understress in adenosine perfusion cardiac magnetic resonance (MR) imaging. Splenic switch-off was assessed in perfusion cardiac MR examinations from 100 patients (mean age, 62 years [age range
Vidhya M Ravi et al.
Life science alliance, 2(4) (2019-06-30)
When it comes to the human brain, models that closely mimic in vivo conditions are lacking. Living neuronal tissue is the closest representation of the in vivo human brain outside of a living person. Here, we present a method that
Raphaëlle Renard-Penna et al.
Radiology, 275(2), 458-468 (2015-01-20)
To compare the diagnostic performance of the magnetic resonance (MR) imaging-based Prostate Imaging Reporting and Data System (PI-RADS) and a Likert scale in the detection of prostate cancer in a cohort of patients undergoing initial prostate biopsy. This institutional review

Related Content

Product Information Sheet

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service